Timothy Daley
Stock Analyst at Wells Fargo
(2.47)
# 2,388
Out of 4,761 analysts
58
Total ratings
51.43%
Success rate
0.52%
Average return
Main Sectors:
Stocks Rated by Timothy Daley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Initiates: Equal-Weight | $47 | $39.57 | +17.97% | 1 | Dec 19, 2023 | |
| MYGN Myriad Genetics | Initiates: Equal-Weight | $20 | $14.18 | +41.04% | 1 | Dec 19, 2023 | |
| RVTY Revvity | Initiates: Equal-Weight | $95 | $113.84 | -16.55% | 1 | Dec 19, 2023 | |
| BRKR Bruker | Initiates: Equal-Weight | $72 | $50.82 | +41.68% | 1 | Dec 19, 2023 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $145 | $135.37 | +7.11% | 5 | Nov 22, 2023 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,520 → $1,300 | $1,286.54 | +1.05% | 5 | Nov 13, 2023 | |
| WAT Waters | Maintains: Equal-Weight | $305 → $285 | $374.82 | -23.96% | 5 | Nov 8, 2023 | |
| DHR Danaher | Maintains: Overweight | $285 → $247 | $210.23 | +17.49% | 3 | Oct 3, 2023 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $280 → $275 | $163.02 | +68.69% | 4 | Sep 22, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $290 → $270 | $249.85 | +8.06% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $28 | $10.04 | +178.88% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $35 | $20.90 | +67.46% | 6 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $505 → $520 | $532.55 | -2.36% | 3 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $4.06 | +121.67% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $185 | $158.99 | +16.36% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $80 → $85 | $64.49 | +31.80% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $235 → $220 | $191.04 | +15.16% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $245 → $220 | $201.39 | +9.24% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $28 | $17.30 | +61.85% | 4 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $135 → $140 | $172.24 | -18.72% | 2 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $90 | $64.92 | +38.63% | 3 | Jan 10, 2023 |
Qiagen
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $47
Current: $39.57
Upside: +17.97%
Myriad Genetics
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $20
Current: $14.18
Upside: +41.04%
Revvity
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $95
Current: $113.84
Upside: -16.55%
Bruker
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $72
Current: $50.82
Upside: +41.68%
Agilent Technologies
Nov 22, 2023
Maintains: Overweight
Price Target: $160 → $145
Current: $135.37
Upside: +7.11%
Mettler-Toledo International
Nov 13, 2023
Maintains: Overweight
Price Target: $1,520 → $1,300
Current: $1,286.54
Upside: +1.05%
Waters
Nov 8, 2023
Maintains: Equal-Weight
Price Target: $305 → $285
Current: $374.82
Upside: -23.96%
Danaher
Oct 3, 2023
Maintains: Overweight
Price Target: $285 → $247
Current: $210.23
Upside: +17.49%
Charles River Laboratories International
Sep 22, 2023
Maintains: Overweight
Price Target: $280 → $275
Current: $163.02
Upside: +68.69%
Labcorp Holdings
Aug 14, 2023
Maintains: Overweight
Price Target: $290 → $270
Current: $249.85
Upside: +8.06%
Aug 14, 2023
Maintains: Overweight
Price Target: $22 → $28
Current: $10.04
Upside: +178.88%
Jul 31, 2023
Maintains: Overweight
Price Target: $30 → $35
Current: $20.90
Upside: +67.46%
Jul 28, 2023
Maintains: Underweight
Price Target: $505 → $520
Current: $532.55
Upside: -2.36%
Jul 20, 2023
Initiates: Overweight
Price Target: $9
Current: $4.06
Upside: +121.67%
Jul 20, 2023
Initiates: Overweight
Price Target: $185
Current: $158.99
Upside: +16.36%
May 2, 2023
Maintains: Equal-Weight
Price Target: $80 → $85
Current: $64.49
Upside: +31.80%
May 1, 2023
Maintains: Equal-Weight
Price Target: $235 → $220
Current: $191.04
Upside: +15.16%
May 1, 2023
Maintains: Equal-Weight
Price Target: $245 → $220
Current: $201.39
Upside: +9.24%
Feb 8, 2023
Maintains: Overweight
Price Target: $25 → $28
Current: $17.30
Upside: +61.85%
Feb 3, 2023
Maintains: Equal-Weight
Price Target: $135 → $140
Current: $172.24
Upside: -18.72%
Jan 10, 2023
Upgrades: Equal-Weight
Price Target: $90
Current: $64.92
Upside: +38.63%